市場調査レポート

商品コード

1525475

デジタルパソロジーの世界市場の評価：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Digital Pathology Market Assessment, By Product, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年08月02日
発行: Markets & Data
ページ情報: 英文 225 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,800 708,768円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 6,000 885,960円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,500 1,255,110円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=147.66円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界のデジタルパソロジーの市場規模は、2023年の10億米ドルから2031年に25億7,000万米ドルに達すると予測され、予測期間の2024年～2031年にCAGRで12.50%の成長が見込まれます。市場は、医療ITとバイオテクノロジー産業の重要な一部であり、医療市場でもっとも速い成長率となっています。デジタルパソロジー技術の採用の増加、AIと機械学習の統合、慢性疾患の有病率の増加などの要因が市場を牽引しています。

デジタルパソロジーは、デジタル標本スライドから収集したデータの管理を扱います。デジタルパソロジーでは、コンピューターベースの技術を用いた仮想顕微鏡が使用されます。ガラスから作られたデジタルスライドは、コンピューター画面上で管理、共有、検査、分析ができます。現代の病理学には新しいアプローチが必要であり、デジタルパソロジーは分析の向上、エラーの減少、よりよい表示、スムーズなワークフロー、所要時間の短縮など、数多くの利点をもたらします。医療における機械学習とAIの進歩により、デジタルパソロジーの分野は拡大し、ホールスライドイメージング（WSI）を用いた診断医療への応用が認識されつつあります。これらの応用の目標は、正確で安価な疾患診断、予後、予測を実現することです。

AGFA Healthcare N.V.とCorista LLCは、北米で病理学のデジタルトランスフォーメーションに向けた統合ソリューションを2024年7月に発売すると発表しました。この先進技術は、病理学部門がアナログ環境からデジタル環境へ移行する際に生じる困難を克服するのに役立ちます。これらの困難には、複雑性の軽減、臨床協力の強化、業務効率の促進が含まれます。AGFAのエンタープライズイメージングプラットフォームは、複数のサービスラインにわたり、安全でカスタマイズ可能な画像統合アプローチを導入することを可能にします。

慢性疾患の増加が市場需要を加速する

糖尿病や心臓病などの長期的な健康問題の増加は、病院やその入院病棟に大きな負担をかけています。スマートフォンアプリや医療機器のようなmヘルス技術によって、患者は自宅から自分の健康に目を配り、自分自身をケアし、定期的に医師と話すことができます。British Heart Foundationのレポートによると、約2億人が冠動脈疾患（CAD）を患っており、世界全体の冠動脈疾患患者のうち、男性が57.89％、女性が42.11％を占めています。IDF（International Diabetes Federation）によれば、世界全体で5億3,700万人以上の成人が糖尿病を患っています。

デジタルパソロジー市場を進化させるAIと機械学習の統合

より多くの検査室が人工ニューラルネットワークを使用して分析を強化する中、技術の進歩によりデジタルパソロジー検査はますます普及しています。ホールスライドイメージ（WSI）は、デジタルパソロジーにおける用途の顕著な例です。顕微鏡スライドはWSIによってデジタルスキャンされ、コンピューターに読み込まれます。その後、ユーザーはAIベースの解析に画像改良やデジタル変換手法を使用することができます。医療関係者にとって、効果的ながん治療を開発することは常に問題でした。従来の生検による所見は非常に正確ですが、データの処理と解釈には長い時間がかかります。AIシステムは必要なデータを素早く収集および分析し、正確ながん診断を行い、結果を出すことができます。2024年5月、Microsoftはワシントン大学とProvidenceの医療ネットワークと協力し、デジタルパソロジー診断向けのホールスライドAIモデルを立ち上げることを発表しました。研究チームは、実環境で実施された全スライド組織分析におけるもっとも大規模なAIトレーニングプロジェクトの1つに基づく機械学習モデルを発表しました。

当レポートでは、世界のデジタルパソロジー市場について調査分析し、市場規模と予測、各地域の市場見通し、市場力学、競合情勢などを提供しています。

市場規模の分析と予測
- 金額
- 数量
市場シェア分析と予測
- 製品別
- タイプ別
- 用途別
- エンドユーザー別
- 地域別
- 市場シェア分析：企業別（金額）（上位5社とその他 - 2023年）
市場マップ分析（2023年）
- 製品別
- タイプ別
- 用途別
- エンドユーザー別
- 地域別

第5章北米のデジタルパソロジー市場の見通し（2017年～2031年）

市場規模の分析と予測
- 金額
- 数量
市場シェア分析と予測
- 製品別
- タイプ別
- 用途別
- エンドユーザー別
- シェア：国別
市場の評価：国別
- 米国のデジタルパソロジー市場の見通し、2017年～2031年予測
- カナダ
- メキシコ

第6章欧州のデジタルパソロジー市場の見通し（2017年～2031年）

ドイツ
フランス
イタリア
英国
ロシア
オランダ
スペイン
トルコ
ポーランド

第7章アジア太平洋のデジタルパソロジー市場の見通し（2017年～2031年）

インド
中国
日本
オーストラリア
ベトナム
韓国
インドネシア
フィリピン

第8章南米のデジタルパソロジー市場の見通し（2017年～2031年）

ブラジル
アルゼンチン

第9章中東・アフリカのデジタルパソロジー市場の見通し（2017年～2031年）

サウジアラビア
アラブ首長国連邦
南アフリカ

第10章需給分析

第11章輸入輸出分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第14章 PESTLE分析

第15章価格分析

第16章市場力学

市場促進要因
市場の課題

第17章市場の動向と発展

第18章規制枠組みとイノベーション

臨床試験
規制当局の承認

第19章特許情勢

第20章ケーススタディ

第21章競合情勢

マーケットリーダー上位5社の競合マトリクス
上位5社のSWOT分析
主要企業上位10社の情勢
- Olympus Corporation
- Koninklijke Philips N.V.
- F. Hoffmann-La Roche Ltd.
- Fujifilm Holdings Corporation
- Danaher Corporation
- Mikroscan Technologies, Inc.
- Inspirata, Inc.
- Mikroscan Technologies Inc.
- Proscia Inc.
- Deep Bio Inc.

第22章戦略的推奨

第23章当社について、免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 3. Global Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 4. Global Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 5. Global Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 6. Global Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 7. Global Digital Pathology Market Share (%), By Region, 2017-2031F
Figure 8. North America Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 10. North America Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 11. North America Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 12. North America Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 13. North America Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 14. North America Digital Pathology Market Share (%), By Country, 2017-2031F
Figure 15. United States Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 17. United States Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 18. United States Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 19. United States Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 20. United States Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 21. Canada Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 23. Canada Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 24. Canada Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 25. Canada Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 26. Canada Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 29. Mexico Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 30. Mexico Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 31. Mexico Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 32. Mexico Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 33. Europe Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 35. Europe Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 36. Europe Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 37. Europe Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 38. Europe Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 39. Europe Digital Pathology Market Share (%), By Country, 2017-2031F
Figure 40. Germany Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 42. Germany Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 43. Germany Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 44. Germany Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 45. Germany Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 46. France Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 47. France Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 48. France Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 49. France Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 50. France Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 51. France Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 52. Italy Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 54. Italy Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 55. Italy Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 56. Italy Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 57. Italy Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 60. United Kingdom Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 61. United Kingdom Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 62. United Kingdom Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 64. Russia Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 66. Russia Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 67. Russia Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 68. Russia Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 69. Russia Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 72. Netherlands Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 73. Netherlands Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 74. Netherlands Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 76. Spain Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 78. Spain Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 79. Spain Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 80. Spain Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 81. Spain Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 84. Turkey Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 85. Turkey Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 86. Turkey Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 87. Turkey Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 88. Poland Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 90. Poland Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 91. Poland Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 92. Poland Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 93. Poland Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 94. South America Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 96. South America Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 97. South America Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 98. South America Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 99. South America Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 100. South America Digital Pathology Market Share (%), By Country, 2017-2031F
Figure 101. Brazil Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 103. Brazil Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 104. Brazil Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 105. Brazil Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 106. Brazil Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 109. Argentina Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 110. Argentina Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 111. Argentina Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 112. Argentina Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 115. Asia-Pacific Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 116. Asia-Pacific Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 117. Asia-Pacific Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific Digital Pathology Market Share (%), By Country, 2017-2031F
Figure 120. India Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 121. India Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 122. India Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 123. India Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 124. India Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 125. India Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 126. China Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 127. China Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 128. China Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 129. China Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 130. China Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 131. China Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 132. Japan Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 134. Japan Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 135. Japan Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 136. Japan Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 137. Japan Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 138. Australia Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 140. Australia Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 141. Australia Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 142. Australia Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 143. Australia Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 146. Vietnam Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 147. Vietnam Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 148. Vietnam Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 152. South Korea Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 153. South Korea Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 154. South Korea Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 155. South Korea Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 158. Indonesia Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 159. Indonesia Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 160. Indonesia Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 164. Philippines Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 165. Philippines Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 166. Philippines Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 167. Philippines Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 170. Middle East & Africa Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 171. Middle East & Africa Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 172. Middle East & Africa Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa Digital Pathology Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 177. Saudi Arabia Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 178. Saudi Arabia Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 179. Saudi Arabia Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 181. UAE Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 183. UAE Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 184. UAE Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 185. UAE Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 186. UAE Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa Digital Pathology Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa Digital Pathology Market, By Volume, In Thousand Units, 2017-2031F
Figure 189. South Africa Digital Pathology Market Share (%), By Product, 2017-2031F
Figure 190. South Africa Digital Pathology Market Share (%), By Type, 2017-2031F
Figure 191. South Africa Digital Pathology Market Share (%), By Application, 2017-2031F
Figure 192. South Africa Digital Pathology Market Share (%), By End-user, 2017-2031F
Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Product Code: MX11696

Global digital pathology market is projected to witness a CAGR of 12.50% during the forecast period 2024-2031, growing from USD 1.00 billion in 2023 to USD 2.57 billion in 2031. The global digital pathology market is an important part of the healthcare IT and biotechnology industry, accounting for one of the fastest growth rates in the healthcare market. Factors are driving the market such as increasing adoption of digital pathology technologies, integration of AI and machine learning, and growing prevalence of chronic diseases.

Digital pathology deals with the management of data gathered from digital specimen slides. Virtual microscopy is used in digital pathology, using computer-based technologies. Digital slides made from glass can be managed, shared, examined, and analyzed on a computer screen. Modern pathologies need new approaches as digital pathology offers numerous benefits such as improved analysis, reduced errors, better views, smooth workflow, and reduced turnaround times. Due to the advancements in machine learning and artificial intelligence in healthcare, the field of digital pathology is expanding and recognizing applications in diagnostic medicine using whole-slide imaging (WSI). The goal of these applications is to achieve accurate and affordable disease diagnosis, prognosis, and prediction.

AGFA Healthcare N.V. and Corista LLC announced the launch of their integrated solution for digital transformation in pathology in North America in July 2024. This advanced technology helps pathology departments overcome the difficulties that occur in moving from an analog to a digital environment. These difficulties involve reducing complexity, enhancing clinical cooperation, and facilitating operational efficiency. The recognized enterprise imaging platform from AGFA makes it possible to implement a safe, customizable picture consolidation approach across several service lines.

Increasing Prevalence of Chronic Diseases to Accelerate the Market Demand

The rise in long-term health problems, such as diabetes and heart issues, puts a lot of pressure on hospitals and their inpatient units. The burden makes people want mobile health (mHealth) options that can help them handle ongoing health conditions better. mHealth technologies such as phone apps and medical devices let patients keep an eye on their health from home, take care of themselves, and talk to their doctors on a regular basis. As per a report from British Heart Foundation, around 200 million people have coronary artery disease (CAD), men and women constituting 57.89% and 42.11%, respectively of the global coronary artery disease patients globally. As per IDF (International Diabetes Federation), more than 537 million adults are living with diabetes globally.

Integration of Artificial Intelligence and Machine Learning to Evolve Digital Pathology Market

Digital pathology has become increasingly popular as a result of technology advancements, as more laboratories use artificial neural networks to enhance their analysis. Whole slide images (WSI) are a prominent example of applications in digital pathology. The microscope slide is digitally scanned by WSI and loaded into a computer. After that, users can use picture improvement and digital transformation methods for AI-based analysis. It has always been a problem for medical professionals to develop effective cancer treatments. The findings of a traditional biopsy are quite accurate, but processing and interpreting the data takes a long time. Artificial intelligence systems can quickly collect and analyze the necessary data, provide accurate cancer diagnoses, and produce results. In May 2024, Microsoft announced its collaboration with the University of Washington and Providence health network with the aim of launching whole-slide AI model for digital pathology. The researchers presented a machine learning model based on one of the most extensive AI training projects in whole-slide tissue analysis conducted in real-world settings.

Device Segment Dominates the Global Digital Pathology Market

The device segment had a dominant share of the global digital pathology market. It is expected to maintain at a lucrative pace throughout the forecast period. The scanner and slide management system are part of the device segment. The growing use of digital pathology for higher-resolution imaging in academic research projects is one of the major reasons behind the segment's growth. The VENTANA DP 600 slide scanner, a next-generation high-capacity device by F. Hoffmann-La Roche Ltd. that produces high-resolution digital pictures of stained tissue samples, assists in cancer diagnosis and treatment planning after the CE mark approval in June 2022.

North America Dominates the Global Digital Pathology Market

In 2023, North America held a dominant position in the global digital pathology market. This was attributed to several factors, including the development of technologically advanced pathologies due to government initiatives, ongoing deployment of R&D investments, presence of healthcare regulatory bodies, rising adoption of digital imaging, and the presence of key market players in the region who were focused on improving living and health conditions of individuals with chronic diseases. To participate in the Early Access Program, PathAI released AISight, a digital pathology platform, in March 2023 in top health systems of 13 nations, reference laboratories, medical facilities, and independent pathology organizations. Additionally, the market is growing due to the growing use of digital pathology in academic research and illness diagnostics. In June 2024, Roche announced that its whole-slide imaging system, the Roche Digital Pathology Dx, received FDA 510(k) approval. The technology analyzes and interprets digital images of scanned pathology slides to facilitate pathologists' diagnostic process. Roche is dedicated to make routine medical diagnosis possible with its digital pathology solutions, and the approval was the first step in that direction.

Future Market Scenario (2024-2031F)

A completely digital workflow from electronic microscopes to cloud-based storage and analysis is expected to accelerate digital pathology market in the forecast period. This will make remote collaboration possible and turn diagnosis faster and more effective.

Artificial intelligence and deep learning technologies will automate tasks, such as pattern recognition and computer-aided diagnosis, in digital pathology market.

More advanced applications, such as forecasting genetic alterations and treatment response based on anatomical characteristics of tissue samples, will be possible through the integration of digital pathology with AI and machine learning.

Digital pathology will enable pathologists to access and interpret slides remotely, which is crucial when there is a projected shortage of pathologists in the future.

Key Players Landscape and Outlook

Several biotechnology companies and IT companies are growing in the digital pathology market by planning and adopting new strategies. They are complying with new strategic initiatives for digital pathology technologies to increase their market presence. New agreements, contracts, acquisitions mergers, investments, and partnerships are major ways through which the market players are trying to achieve a higher market share.

Philips and Amazon Web Services announced their partnership in March 2024 to scale its cloud storage for digital pathology solutions. By enabling more pathology laboratories to use digital processes to boost productivity, Philips and AWS will progress digital pathology and assist pathology labs in effectively managing, storing, and analyzing increasing amounts of digital pathology data.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Digital Pathology Market Outlook, 2017-2031F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. Market Share Analysis & Forecast
- 4.2.1. By Product
  - 4.2.1.1. Software
  - 4.2.1.2. Device
    - 4.2.1.2.1. Scanners
    - 4.2.1.2.2. Slide Management System
  - 4.2.1.3. Storage System
- 4.2.2. By Type
  - 4.2.2.1. Human Pathology
  - 4.2.2.2. Veterinary Pathology
- 4.2.3. By Application
  - 4.2.3.1. Drug Discovery and Drug Development
  - 4.2.3.2. Academics Research
  - 4.2.3.3. Disease Diagnosis
- 4.2.4. By End-user
  - 4.2.4.1. Hospitals
  - 4.2.4.2. Biotechnology and Pharma Companies
  - 4.2.4.3. Diagnostic Labs
  - 4.2.4.4. Academic and Research Institutes
- 4.2.5. By Region
  - 4.2.5.1. North America
  - 4.2.5.2. Europe
  - 4.2.5.3. Asia-Pacific
  - 4.2.5.4. South America
  - 4.2.5.5. Middle East and Africa
- 4.2.6. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
4.3. Market Map Analysis, 2023
- 4.3.1. By Product
- 4.3.2. By Type
- 4.3.3. By Application
- 4.3.4. By End-user
- 4.3.5. By Region

5. North America Digital Pathology Market Outlook, 2017-2031F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
- 5.1.2. By Volume
5.2. Market Share Analysis & Forecast
- 5.2.1. By Product
  - 5.2.1.1. Software
  - 5.2.1.2. Device
    - 5.2.1.2.1. Scanners
    - 5.2.1.2.2. Slide Management System
  - 5.2.1.3. Storage System
- 5.2.2. By Type
  - 5.2.2.1. Human Pathology
  - 5.2.2.2. Veterinary Pathology
- 5.2.3. By Application
  - 5.2.3.1. Drug Discovery and Drug Development
  - 5.2.3.2. Academics Research
  - 5.2.3.3. Disease Diagnosis
- 5.2.4. By End-user
  - 5.2.4.1. Hospitals
  - 5.2.4.2. Biotechnology and Pharma Companies
  - 5.2.4.3. Diagnostic Labs
  - 5.2.4.4. Academic and Research Institutes
- 5.2.5. By Country Share
  - 5.2.5.1. United States
  - 5.2.5.2. Canada
  - 5.2.5.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Digital Pathology Market Outlook, 2017-2031F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
    - 5.3.1.1.2. By Volume
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Product
      - 5.3.1.2.1.1. Software
      - 5.3.1.2.1.2. Device
      - 5.3.1.2.1.2.1. Scanners
      - 5.3.1.2.1.2.2. Slide Management System
      - 5.3.1.2.1.3. Storage System
    - 5.3.1.2.2. By Type
      - 5.3.1.2.2.1. Human Pathology
      - 5.3.1.2.2.2. Veterinary Pathology
    - 5.3.1.2.3. By Application
      - 5.3.1.2.3.1. Drug Discovery and Drug Development
      - 5.3.1.2.3.2. Academics Research
      - 5.3.1.2.3.3. Disease Diagnosis
    - 5.3.1.2.4. By End-user
      - 5.3.1.2.4.1. Hospitals
      - 5.3.1.2.4.2. Biotechnology and Pharma Companies
      - 5.3.1.2.4.3. Diagnostic Labs
      - 5.3.1.2.4.4. Academic and Research Institutes
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Digital Pathology Market Outlook, 2017-2031F

6.1. Germany
6.2. France
6.3. Italy
6.4. United Kingdom
6.5. Russia
6.6. Netherlands
6.7. Spain
6.8. Turkey
6.9. Poland

7. Asia-Pacific Digital Pathology Market Outlook, 2017-2031F

7.1. India
7.2. China
7.3. Japan
7.4. Australia
7.5. Vietnam
7.6. South Korea
7.7. Indonesia
7.8. Philippines

8. South America Digital Pathology Market Outlook, 2017-2031F

8.1. Brazil
8.2. Argentina

9. Middle East and Africa Digital Pathology Market Outlook, 2017-2031F

9.1. Saudi Arabia
9.2. UAE
9.3. South Africa

10. Demand Supply Analysis

11. Import Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

16.1. Market Drivers
16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

18.1. Clinical Trials
18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. Olympus Corporation
  - 21.3.1.1. Company Details
  - 21.3.1.2. Key Management Personnel
  - 21.3.1.3. Products and Services
  - 21.3.1.4. Financials (As Reported)
  - 21.3.1.5. Key Market Focus and Geographical Presence
  - 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
- 21.3.2. Koninklijke Philips N.V.
- 21.3.3. F. Hoffmann-La Roche Ltd.
- 21.3.4. Fujifilm Holdings Corporation
- 21.3.5. Danaher Corporation
- 21.3.6. Mikroscan Technologies, Inc.
- 21.3.7. Inspirata, Inc.
- 21.3.8. Mikroscan Technologies Inc.
- 21.3.9. Proscia Inc.
- 21.3.10. Deep Bio Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

デジタルパソロジーの世界市場の評価：製品タイプ別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

Digital Pathology Market Assessment, By Product, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界のデジタルパソロジー市場の見通し（2017年～2031年）

第5章 北米のデジタルパソロジー市場の見通し（2017年～2031年）

第6章 欧州のデジタルパソロジー市場の見通し（2017年～2031年）

第7章 アジア太平洋のデジタルパソロジー市場の見通し（2017年～2031年）

第8章 南米のデジタルパソロジー市場の見通し（2017年～2031年）

第9章 中東・アフリカのデジタルパソロジー市場の見通し（2017年～2031年）

第10章 需給分析

第11章 輸入輸出分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析